CLINICAL_TRIALS
ClinicalTrials.gov record update
A Multinational, Multicenter, Open-Label Phase II Study of SyB L-0501 in Combination With Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01118845
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:28.739594+00:00
- Published At
- 2013-07-04T00:00:00+00:00
- Record Updated At
- 2013-07-04
- Results Posted At
- 2013-07-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non-Hodgkin\u0027s Lymphoma", "Lymphoma, Large Cell", "Diffuse, Mantle Cell Lymphoma, Lymphoma", "Follicular Lymphoma", "Large B-Cell, Diffuse"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-07-04"- protocolSection.identificationModule.nctId
"NCT01118845"- protocolSection.identificationModule.officialTitle
"A Multinational, Multicenter, Open-Label Phase II Study of SyB L-0501 in Combination With Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-07-04"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.